Sanofi to establish mRNA vaccine center with 400 employees

The vaccine division of the pharmaceutical company Sanofi is now betting everything it has on becoming a leading actor in the market for mRNA vaccines, according to a Tuesday press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Sanofi reveals detailed timeframe for RSV candidate
For subscribers
Three global giants consider vaccine production in Denmark
For subscribers